Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(1073)

S5 - E7.2 - Identifying the target MASH patients for Rezdiffra

S5 - E7.2 - Identifying the target MASH patients for Rezdiffra

Send us Fan Mail This conversation focuses on two issues: (i) identifying the right target MASH patients for Rezdiffra, and (ii) the extensive Madrigal patient support program for Rezdiffra. It start...

23 Maalis 20249min

S5 - E7 - MASLD Patient Advocates Celebrate Rezdiffra and Discuss the Future

S5 - E7 - MASLD Patient Advocates Celebrate Rezdiffra and Discuss the Future

Send us Fan Mail Last Thursday, March 14, Rezdiffra (resmetirom) became the first drug approved in the US for MASH. Five leading North American MASLD patient advocates join the Surfers to discuss thei...

21 Maalis 20241h 5min

S5 - E6.6 - Closing Question From The Episode On Rezdiffra, The First MASH Drug

S5 - E6.6 - Closing Question From The Episode On Rezdiffra, The First MASH Drug

Send us Fan Mail As the conversation wound down, Roger Green offered panelists to address any issue pertaining to Rezdiffra, the first MASH drug, that had not come up in the hour-long conversation. ...

19 Maalis 20248min

S5 - E6.5 - BioPharma Industry Takeaways ForBioPharma Industry Takeaways From The Rezdiffra Launch The Rezdiffra Launch

S5 - E6.5 - BioPharma Industry Takeaways ForBioPharma Industry Takeaways From The Rezdiffra Launch The Rezdiffra Launch

Send us Fan Mail This conversation revolves around one question: "What lessons should the BioPharma industry take from the launch of Rezdiffra?" Answers revolve largely around clinical trial design an...

19 Maalis 20247min

S5 - E6.4 - Finding The MASH Patients That Are The Initial Rezdiffra Targets

S5 - E6.4 - Finding The MASH Patients That Are The Initial Rezdiffra Targets

Send us Fan Mail One pivotal question surrounding the launch of Rezdiffra is "Which MASH patients are the correct targets for the first MASH drug?" This conversation focuses on the tools and education...

19 Maalis 202412min

S5 - E6.3 - Staging and screening patients for Rezdiffra using NITs

S5 - E6.3 - Staging and screening patients for Rezdiffra using NITs

Send us Fan Mail This conversation focuses on the necessity of using NITs to screen and identify Rezdiffra patients, while at the same time acknowledging the shortcomings of current tests. Panelists s...

18 Maalis 202415min

S5 - E6.2 - How Approval Of Rezdiffra,The First MASH Drug, Might Improve Patient Adherence To Lifestyle Recommendations

S5 - E6.2 - How Approval Of Rezdiffra,The First MASH Drug, Might Improve Patient Adherence To Lifestyle Recommendations

Send us Fan Mail This conversation focuses on what panelists see as a key (and somewhat unusual) benefit of Rezdiffra: that having a prescription drug for MASH creates a better environment for discuss...

18 Maalis 202411min

S5 - E6.1 - Rezdiffra Is Approved! How Key Opinion Leaders Processed The News About The First MASH Drug

S5 - E6.1 - Rezdiffra Is Approved! How Key Opinion Leaders Processed The News About The First MASH Drug

Send us Fan Mail FDA approval of the first MASH drug, Rezdiffra, on March 14 marked what co-host and Key Opinion Leader Jörn Schattenberg describes as a "watershed moment" for hepatology. This opening...

18 Maalis 202411min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
hippokrateen-vastaanotolla
filocast-filosofian-perusteet
rss-ammamafia
rss-tiedetta-vai-tarinaa
docemilia
tiedekulma-podcast
ihanat-ipanat
radio-antro
rss-bios-podcast
rss-vaasan-yliopiston-podcastit
rss-duodecim-lehti
rss-hereilla
rss-totuuden-liepeilla